---
$id: https://graph.org.ai/products/commodity/51392224
$type: Product
source: UNSPSC
code: "51392224"
title: "Lofexidine hydrochloride"
class: "51392200"
classTitle: "Sympathomimetic or adrenergic imidazoles"
family: "51390000"
familyTitle: "Sympathomimetic or adrenergic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lofexidine hydrochloride

**UNSPSC Code**: 51392224
**Class**: [Sympathomimetic or adrenergic imidazoles](Sympathomimetic or adrenergic imidazoles.mdx)
**Family**: [Sympathomimetic or adrenergic drugs](../Sympathomimetic or adrenergic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alpha-adrenergic agonist with the molecular formula C11H12Cl2N2O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V47G1SDI1B, chemically known as 2-imidazoline, 2-(1-(2,6-dichlorophenoxy)ethyl)-, monohydrochloride but more generally known as lofexidine hydrochloride, which bears US NIH Compound Identifier 30667. European Medicines Agency schedules Lofexidine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02966MIG. Most nations, for tariff and trade purposes, schedule lofexidine hydrochloride under HS 29332990. As of Q4 2014, LOFEXIDINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Lofexidine hydrochloride bears US NLM identifiers UMLS ID C0771049 and NCI Concept Code C87581. SMILES: CC(C1=NCCN1)OC2C(CCCC2CL)CL.CL.

